COVID-19 Impact on Global Viral Vaccines, Market Insights and Forecast to 2026
- BMR3903738
- 118 Pages
- June 2020
- Healthcare
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Viral Vaccines industry.
Based on our recent survey, we have several different scenarios about the Viral Vaccines YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Viral Vaccines will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Viral Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Viral Vaccines market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Viral Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Viral Vaccines market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Viral Vaccines market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Viral Vaccines market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Viral Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Viral Vaccines market.
The following manufacturers are covered in this report:
GSK
Merck
Novartis
Pfizer
Sanofi
Bayer
Zoetis
AstraZeneca
Johnson
CSL
Viral Vaccines Breakdown Data by Type
Attenuated Vaccine
Inactivated Vaccine
Viral Vaccines Breakdown Data by Application
Hospital
Pharmaceutical Factory
Research Institute
Others
1.1 Viral Vaccines Product Introduction
1.2 Market Segments
1.3 Key Viral Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Viral Vaccines Market Size Growth Rate by Type
1.4.2 Attenuated Vaccine
1.4.3 Inactivated Vaccine
1.5 Market by Application
1.5.1 Global Viral Vaccines Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Pharmaceutical Factory
1.5.4 Research Institute
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Viral Vaccines Industry Impact
1.6.1 How the Covid-19 is Affecting the Viral Vaccines Industry
1.6.1.1 Viral Vaccines Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Viral Vaccines Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Viral Vaccines Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Viral Vaccines Market Size Estimates and Forecasts
2.1.1 Global Viral Vaccines Revenue 2015-2026
2.1.2 Global Viral Vaccines Sales 2015-2026
2.2 Viral Vaccines Market Size by Region: 2020 Versus 2026
2.2.1 Global Viral Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Viral Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Viral Vaccines Competitor Landscape by Players
3.1 Viral Vaccines Sales by Manufacturers
3.1.1 Viral Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Viral Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Viral Vaccines Revenue by Manufacturers
3.2.1 Viral Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Viral Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Viral Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Viral Vaccines Revenue in 2019
3.2.5 Global Viral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Viral Vaccines Price by Manufacturers
3.4 Viral Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Viral Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Viral Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Viral Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Viral Vaccines Market Size by Type (2015-2020)
4.1.1 Global Viral Vaccines Sales by Type (2015-2020)
4.1.2 Global Viral Vaccines Revenue by Type (2015-2020)
4.1.3 Viral Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Viral Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Viral Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Viral Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Viral Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Viral Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Viral Vaccines Market Size by Application (2015-2020)
5.1.1 Global Viral Vaccines Sales by Application (2015-2020)
5.1.2 Global Viral Vaccines Revenue by Application (2015-2020)
5.1.3 Viral Vaccines Price by Application (2015-2020)
5.2 Viral Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Viral Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Viral Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Viral Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Viral Vaccines by Country
6.1.1 North America Viral Vaccines Sales by Country
6.1.2 North America Viral Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Viral Vaccines Market Facts & Figures by Type
6.3 North America Viral Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Viral Vaccines by Country
7.1.1 Europe Viral Vaccines Sales by Country
7.1.2 Europe Viral Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Viral Vaccines Market Facts & Figures by Type
7.3 Europe Viral Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Viral Vaccines by Region
8.1.1 Asia Pacific Viral Vaccines Sales by Region
8.1.2 Asia Pacific Viral Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Viral Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Viral Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Viral Vaccines by Country
9.1.1 Latin America Viral Vaccines Sales by Country
9.1.2 Latin America Viral Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Viral Vaccines Market Facts & Figures by Type
9.3 Central & South America Viral Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Viral Vaccines by Country
10.1.1 Middle East and Africa Viral Vaccines Sales by Country
10.1.2 Middle East and Africa Viral Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Viral Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Viral Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description, Business Overview and Total Revenue
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Viral Vaccines Products Offered
11.1.5 GSK Recent Development
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description, Business Overview and Total Revenue
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Viral Vaccines Products Offered
11.2.5 Merck Recent Development
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Description, Business Overview and Total Revenue
11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis Viral Vaccines Products Offered
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description, Business Overview and Total Revenue
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Viral Vaccines Products Offered
11.4.5 Pfizer Recent Development
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Description, Business Overview and Total Revenue
11.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanofi Viral Vaccines Products Offered
11.5.5 Sanofi Recent Development
11.6 Bayer
11.6.1 Bayer Corporation Information
11.6.2 Bayer Description, Business Overview and Total Revenue
11.6.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bayer Viral Vaccines Products Offered
11.6.5 Bayer Recent Development
11.7 Zoetis
11.7.1 Zoetis Corporation Information
11.7.2 Zoetis Description, Business Overview and Total Revenue
11.7.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Zoetis Viral Vaccines Products Offered
11.7.5 Zoetis Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Description, Business Overview and Total Revenue
11.8.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.8.4 AstraZeneca Viral Vaccines Products Offered
11.8.5 AstraZeneca Recent Development
11.9 Johnson
11.9.1 Johnson Corporation Information
11.9.2 Johnson Description, Business Overview and Total Revenue
11.9.3 Johnson Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Johnson Viral Vaccines Products Offered
11.9.5 Johnson Recent Development
11.10 CSL
11.10.1 CSL Corporation Information
11.10.2 CSL Description, Business Overview and Total Revenue
11.10.3 CSL Sales, Revenue and Gross Margin (2015-2020)
11.10.4 CSL Viral Vaccines Products Offered
11.10.5 CSL Recent Development
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description, Business Overview and Total Revenue
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Viral Vaccines Products Offered
11.1.5 GSK Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Viral Vaccines Market Estimates and Projections by Region
12.1.1 Global Viral Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Viral Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Viral Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Viral Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Viral Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Viral Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Viral Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Viral Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Viral Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Viral Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Viral Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Viral Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Viral Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Viral Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Viral Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Viral Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Viral Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Viral Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Viral Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Viral Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Viral Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Viral Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Viral Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Viral Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
Table 1. Viral Vaccines Market Segments
Table 2. Ranking of Global Top Viral Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Viral Vaccines Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Attenuated Vaccine
Table 5. Major Manufacturers of Inactivated Vaccine
Table 6. COVID-19 Impact Global Market: (Four Viral Vaccines Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Viral Vaccines Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Viral Vaccines Players to Combat Covid-19 Impact
Table 11. Global Viral Vaccines Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Viral Vaccines Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Viral Vaccines Sales by Regions 2015-2020 (K MT)
Table 14. Global Viral Vaccines Sales Market Share by Regions (2015-2020)
Table 15. Global Viral Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Viral Vaccines Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Viral Vaccines Sales Share by Manufacturers (2015-2020)
Table 18. Global Viral Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Viral Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vaccines as of 2019)
Table 20. Viral Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Viral Vaccines Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Viral Vaccines Price (2015-2020) (USD/MT)
Table 23. Viral Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Viral Vaccines Product Type
Table 25. Date of International Manufacturers Enter into Viral Vaccines Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Viral Vaccines Sales by Type (2015-2020) (K MT)
Table 28. Global Viral Vaccines Sales Share by Type (2015-2020)
Table 29. Global Viral Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Viral Vaccines Revenue Share by Type (2015-2020)
Table 31. Viral Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Viral Vaccines Sales by Application (2015-2020) (K MT)
Table 33. Global Viral Vaccines Sales Share by Application (2015-2020)
Table 34. North America Viral Vaccines Sales by Country (2015-2020) (K MT)
Table 35. North America Viral Vaccines Sales Market Share by Country (2015-2020)
Table 36. North America Viral Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Viral Vaccines Revenue Market Share by Country (2015-2020)
Table 38. North America Viral Vaccines Sales by Type (2015-2020) (K MT)
Table 39. North America Viral Vaccines Sales Market Share by Type (2015-2020)
Table 40. North America Viral Vaccines Sales by Application (2015-2020) (K MT)
Table 41. North America Viral Vaccines Sales Market Share by Application (2015-2020)
Table 42. Europe Viral Vaccines Sales by Country (2015-2020) (K MT)
Table 43. Europe Viral Vaccines Sales Market Share by Country (2015-2020)
Table 44. Europe Viral Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Viral Vaccines Revenue Market Share by Country (2015-2020)
Table 46. Europe Viral Vaccines Sales by Type (2015-2020) (K MT)
Table 47. Europe Viral Vaccines Sales Market Share by Type (2015-2020)
Table 48. Europe Viral Vaccines Sales by Application (2015-2020) (K MT)
Table 49. Europe Viral Vaccines Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Viral Vaccines Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Viral Vaccines Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Viral Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Viral Vaccines Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Viral Vaccines Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Viral Vaccines Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Viral Vaccines Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Viral Vaccines Sales Market Share by Application (2015-2020)
Table 58. Latin America Viral Vaccines Sales by Country (2015-2020) (K MT)
Table 59. Latin America Viral Vaccines Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Viral Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Viral Vaccines Revenue Market Share by Country (2015-2020)
Table 62. Latin America Viral Vaccines Sales by Type (2015-2020) (K MT)
Table 63. Latin America Viral Vaccines Sales Market Share by Type (2015-2020)
Table 64. Latin America Viral Vaccines Sales by Application (2015-2020) (K MT)
Table 65. Latin America Viral Vaccines Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Viral Vaccines Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Viral Vaccines Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Viral Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Viral Vaccines Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Viral Vaccines Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Viral Vaccines Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Viral Vaccines Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Viral Vaccines Sales Market Share by Application (2015-2020)
Table 74. GSK Corporation Information
Table 75. GSK Description and Major Businesses
Table 76. GSK Viral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. GSK Product
Table 78. GSK Recent Development
Table 79. Merck Corporation Information
Table 80. Merck Description and Major Businesses
Table 81. Merck Viral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Merck Product
Table 83. Merck Recent Development
Table 84. Novartis Corporation Information
Table 85. Novartis Description and Major Businesses
Table 86. Novartis Viral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Novartis Product
Table 88. Novartis Recent Development
Table 89. Pfizer Corporation Information
Table 90. Pfizer Description and Major Businesses
Table 91. Pfizer Viral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Pfizer Product
Table 93. Pfizer Recent Development
Table 94. Sanofi Corporation Information
Table 95. Sanofi Description and Major Businesses
Table 96. Sanofi Viral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Sanofi Product
Table 98. Sanofi Recent Development
Table 99. Bayer Corporation Information
Table 100. Bayer Description and Major Businesses
Table 101. Bayer Viral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Bayer Product
Table 103. Bayer Recent Development
Table 104. Zoetis Corporation Information
Table 105. Zoetis Description and Major Businesses
Table 106. Zoetis Viral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Zoetis Product
Table 108. Zoetis Recent Development
Table 109. AstraZeneca Corporation Information
Table 110. AstraZeneca Description and Major Businesses
Table 111. AstraZeneca Viral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. AstraZeneca Product
Table 113. AstraZeneca Recent Development
Table 114. Johnson Corporation Information
Table 115. Johnson Description and Major Businesses
Table 116. Johnson Viral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Johnson Product
Table 118. Johnson Recent Development
Table 119. CSL Corporation Information
Table 120. CSL Description and Major Businesses
Table 121. CSL Viral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. CSL Product
Table 123. CSL Recent Development
Table 124. Global Viral Vaccines Sales Forecast by Regions (2021-2026) (K MT)
Table 125. Global Viral Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 126. Global Viral Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 127. Global Viral Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 128. North America: Viral Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 129. North America: Viral Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Europe: Viral Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 131. Europe: Viral Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Asia Pacific: Viral Vaccines Sales Forecast by Region (2021-2026) (K MT)
Table 133. Asia Pacific: Viral Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Latin America: Viral Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 135. Latin America: Viral Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Middle East and Africa: Viral Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 137. Middle East and Africa: Viral Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Main Points Interviewed from Key Viral Vaccines Players
Table 142. Viral Vaccines Customers List
Table 143. Viral Vaccines Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Viral Vaccines Product Picture
Figure 2. Global Viral Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Attenuated Vaccine Product Picture
Figure 4. Inactivated Vaccine Product Picture
Figure 5. Global Viral Vaccines Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Pharmaceutical Factory
Figure 8. Research Institute
Figure 9. Others
Figure 10. Viral Vaccines Report Years Considered
Figure 11. Global Viral Vaccines Market Size 2015-2026 (US$ Million)
Figure 12. Global Viral Vaccines Sales 2015-2026 (K MT)
Figure 13. Global Viral Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Viral Vaccines Sales Market Share by Region (2015-2020)
Figure 15. Global Viral Vaccines Sales Market Share by Region in 2019
Figure 16. Global Viral Vaccines Revenue Market Share by Region (2015-2020)
Figure 17. Global Viral Vaccines Revenue Market Share by Region in 2019
Figure 18. Global Viral Vaccines Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Viral Vaccines Revenue in 2019
Figure 20. Viral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Viral Vaccines Sales Market Share by Type (2015-2020)
Figure 22. Global Viral Vaccines Sales Market Share by Type in 2019
Figure 23. Global Viral Vaccines Revenue Market Share by Type (2015-2020)
Figure 24. Global Viral Vaccines Revenue Market Share by Type in 2019
Figure 25. Global Viral Vaccines Market Share by Price Range (2015-2020)
Figure 26. Global Viral Vaccines Sales Market Share by Application (2015-2020)
Figure 27. Global Viral Vaccines Sales Market Share by Application in 2019
Figure 28. Global Viral Vaccines Revenue Market Share by Application (2015-2020)
Figure 29. Global Viral Vaccines Revenue Market Share by Application in 2019
Figure 30. North America Viral Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Viral Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Viral Vaccines Sales Market Share by Country in 2019
Figure 33. North America Viral Vaccines Revenue Market Share by Country in 2019
Figure 34. U.S. Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Viral Vaccines Market Share by Type in 2019
Figure 39. North America Viral Vaccines Market Share by Application in 2019
Figure 40. Europe Viral Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Viral Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Viral Vaccines Sales Market Share by Country in 2019
Figure 43. Europe Viral Vaccines Revenue Market Share by Country in 2019
Figure 44. Germany Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Viral Vaccines Market Share by Type in 2019
Figure 55. Europe Viral Vaccines Market Share by Application in 2019
Figure 56. Asia Pacific Viral Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Viral Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Viral Vaccines Sales Market Share by Region in 2019
Figure 59. Asia Pacific Viral Vaccines Revenue Market Share by Region in 2019
Figure 60. China Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Viral Vaccines Market Share by Type in 2019
Figure 83. Asia Pacific Viral Vaccines Market Share by Application in 2019
Figure 84. Latin America Viral Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Viral Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Viral Vaccines Sales Market Share by Country in 2019
Figure 87. Latin America Viral Vaccines Revenue Market Share by Country in 2019
Figure 88. Mexico Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Viral Vaccines Market Share by Type in 2019
Figure 95. Latin America Viral Vaccines Market Share by Application in 2019
Figure 96. Middle East and Africa Viral Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Viral Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Viral Vaccines Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Viral Vaccines Revenue Market Share by Country in 2019
Figure 100. Turkey Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Viral Vaccines Market Share by Type in 2019
Figure 107. Middle East and Africa Viral Vaccines Market Share by Application in 2019
Figure 108. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. North America Viral Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. North America Viral Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Europe Viral Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 121. Europe Viral Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Asia Pacific Viral Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 123. Asia Pacific Viral Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Latin America Viral Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 125. Latin America Viral Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Middle East and Africa Viral Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 127. Middle East and Africa Viral Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Porter's Five Forces Analysis
Figure 129. Channels of Distribution
Figure 130. Distributors Profiles
Figure 131. Bottom-up and Top-down Approaches for This Report
Figure 132. Data Triangulation
Figure 133. Key Executives Interviewed
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
